ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review
Authors
Sandip Ravandale , Ritesh Agarwal , Avinash Patil
Keywords
Inflammatory; Neurodegenerative diseases; Treatment; Nanocarrier system; Patents
Abstract
Inflammatory and neurodegenerative disorders, such as Parkinson's disease, affect millions of people worldwide and pose a major risk to public health. About 5 million people worldwide are impacted by it, and by 2030. To treat inflammatory diseases, rheumatoid arthritis, and degenerative diseases, numerous drugs and therapies have been developed; however, these have frequently been associated with side effects, such as drug resistance, poor solubility, decreased bioavailability, and inability to cross the blood–brain barrier (BBB). Nano carrier systems are emerging as a promising therapy option for neuroinflammatory and neurodegenerative disorders, which pose a severe threat to public health due to neuronal loss and impaired brain function. Nanocarrier systems are an excellent option for treating a variety of inflammatory and neurological disorders because of their many benefits. Furthermore, they lessen adverse effects by facilitating the precise administration of drugs to specific CNS tissues or cells. We have summarised the conventional treatment method for inflammatory and neurodegenerative disorders. We have also discussed the potential benefits of nanocarrier systems with current patented worked involved in field of nanocarrier based drug delivery. This work helps researcher for implementation of effective treatment strategy for developing better treatment options inflammatory and neurological disorders.
Full Paper, Downloads & Preview
How To Cite
Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.
IJRTI — journal style
"Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.10, Issue 8, page no.a383-a402, August-2025, Available :https://ijrti.org/papers/IJRTI2508048.pdf
APA — 7th edition
Ravandale, S., Agarwal, R., & Patil, A. (2025). Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review. International Journal for Research Trends and Innovation, 10(8), a383-a402. https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048
MLA — 9th edition
Ravandale, Sandip, et al. "Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review." International Journal for Research Trends and Innovation, vol. 10, no. 8, 2025, pp. a383-a402, https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048.
Chicago — 17th, bibliography
Ravandale, Sandip, Ritesh Agarwal, and Avinash Patil. "Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review." International Journal for Research Trends and Innovation 10, no. 8 (2025): a383-a402. https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048.
Harvard — author–date
Ravandale, S., Agarwal, R. and Patil, A. (2025) 'Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review', International Journal for Research Trends and Innovation, 10(8), pp. a383-a402. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048
IEEE — numbered reference
S. Ravandale, R. Agarwal and A. Patil, "Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review," IJRTI, vol. 10, no. 8, pp. a383-a402, Aug. 2025.
Vancouver — biomedical
Ravandale S, Agarwal R, Patil A. Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review. IJRTI. 2025 Aug;10(8):a383-a402.
AMA — 11th edition
Ravandale S, Agarwal R, Patil A. Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review. IJRTI. 2025;10(8):a383-a402. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2508048,
author = {Sandip Ravandale and Ritesh Agarwal and Avinash Patil},
title = {Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review},
journal = {International Journal for Research Trends and Innovation},
volume = {10},
number = {8},
pages = {a383-a402},
year = {2025},
month = {August},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Ravandale, Sandip
AU - Agarwal, Ritesh
AU - Patil, Avinash
TI - Nanocarrier based drug delivery in inflammatory and Parkinson’s Disease: A Review
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 10
IS - 8
PY - 2025
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048
SP - a383-a402
ER -
Issue
Volume 10 Issue 8,
August-2025
Pages : a383-a402
Other Publication Details
Paper Reg. ID
IJRTI_205657
Published Paper ID
IJRTI2508048
Downloads
205,615
Research Area
Pharmacy
Country
Dhule, Maharashtra, India
Published
August 2025
Published Paper PDF
https://ijrti.org/papers/IJRTI2508048.pdf
Published Paper URL
https://ijrti.org/viewpaperforall.php?paper=IJRTI2508048
About Publisher
International Journal for Research Trends and Innovation
Published by IJRTI (JW Publication)
2456-3315
ISSN
10.57
Impact Factor
2016
ESTD Year
Open
Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Licence
© 2025 — Authors hold the copyright of this article.
This work is licensed under a
Creative Commons Attribution 4.0 International License
and The Open Definition.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0),
which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.
